Persistent cognitive impairment after cerebral malaria: Models, mechanisms and adjunctive therapies

Expert Review of Anti-Infective Therapy

Volumn 8, Issue 11, 2010, Pages 1209-1212

  Zimmerman, Guy A ^a   Castro Faria Neto, Hugo ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

antioxidants; cerebral malaria; cognitive dysfunction; experimental malaria; mouse models; oxidant stress

Indexed keywords

ACETYLCYSTEINE; ANTIMALARIAL AGENT; DEFEROXAMINE;

ADJUVANT THERAPY; BRAIN MALARIA; COGNITIVE DEFECT; DISEASE SEVERITY; EDITORIAL; HISTOPATHOLOGY; HUMAN; MALARIA CONTROL; MALARIA FALCIPARUM; NEUROIMAGING; NEUROPATHOLOGY; NON INVASIVE PROCEDURE; NONHUMAN; OXIDATIVE STRESS; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; POPULATION RISK;

ANIMALS; ANTIMALARIALS; COGNITION DISORDERS; DRUG THERAPY, COMBINATION; HUMANS; MALARIA, CEREBRAL; PLASMODIUM FALCIPARUM;

EID: 78349263498     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.10.117     Document Type: Editorial

References (31)

1. Kappe SH, Vaughan AM, Boddey JA, Cowman AF. That was then but this is now: malaria research in the time of an eradication agenda. Science 328(5980), 862-866 (2010).
2. Hay SI, Okiro EA, Gething PW et al. Estimating the global clinical burden of Plasmodium falciparum malaria in 2007. PLoS Med. 7(6), e1000290 (2010).
3. Rosenthal PJ. Artesunate for the treatment of severe falciparum malaria. N. Engl. J. Med. 358(17), 1829-1836 (2008).
4. De Souza JB, Hafalla JC, Riley EM, Couper KN. Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology 137(5), 755-772 (2010).
5. Golenser J, McQuillan J, Hee L, Mitchell AJ, Hunt NH. Conventional and experimental treatment of cerebral malaria. Int. J. Parasitol. 36(5), 583-593 (2006).
6. Carter JA, Mung'ala-Odera V, Neville BG et al. Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children. J. Neurol. Neurosurg. Psychiatry 76(4), 476-481 (2005).
7. Carter JA, Ross AJ, Neville BG et al. Developmental impairments following severe falciparum malaria in children. Trop. Med. Int. Health 10(1), 3-10 (2005).
8. Boivin MJ, Bangirana P, Byarugaba J et al. Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics 119(2), e360-e366 (2007).
9. John CC, Bangirana P, Byarugaba J et al. Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics 122(1), e92-e99 (2008).
10. Birbeck GL. Seizures in rural Zambia. Epilepsia 41(3), 277-281 (2000).
11. Murphy SC, Breman JG. Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am. J. Trop. Med. Hyg. 64(1-2 Suppl.), 57-67 (2001).
12. Taylor TE, Fu WJ, Carr RA et al. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat. Med. 10(2), 143-145 (2004).
13. Renia L, Gruner AC, Snounou G. Cerebral malaria: in praise of epistemes. Trends Parasitol. 26(6), 275-277 (2010).
14. Charunwatthana P, Abul Faiz M, Ruangveerayut R et al. N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial. Crit. Care Med. 37(2), 516-522 (2009).
15. White NJ, Turner GD, Medana IM, Dondorp AM, Day NP. The murine cerebral malaria phenomenon. Trends Parasitol. 26(1), 11-15 (2009).
16. Quintana-Murci L, Alcais A, Abel L, Casanova JL. Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases. Nat. Immunol. 8(11), 1165-1171 (2007).
17. Reis PA, Comim CM, Hermani F et al. Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy. PLoS Pathog. 6(6), e1000963 (2010).
18. Desruisseaux MS, Gulinello M, Smith DN et al. Cognitive dysfunction in mice infected with Plasmodium berghei strain ANKA. J. Infect. Dis. 197(11), 1621-1627 (2008).
19. Dondorp AM, Omodeo-Sale F, Chotivanich K, Taramelli D, White NJ. Oxidative stress and rheology in severe malaria. Redox Rep. 8(5), 292-294 (2003).
20. Carvalho LJ. Murine cerebral malaria: how far from human cerebral malaria? Trends Parasitol. 26(6), 271-272 (2010).
21. Riley EM, Couper KN, Helmby H et al. Neuropathogenesis of human and murine malaria. Trends Parasitol. 26(6), 277-278 (2010).
22. Ritter C, Andrades ME, Reinke A, Menna-Barreto S, Moreira JC, Dal-Pizzol F. Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit. Care Med. 32(2), 342-349 (2004).
23. Barichello T, Machado RA, Constantino L et al. Antioxidant treatment prevented late memory impairment in an animal model of sepsis. Crit. Care Med. 35(9), 2186-2190 (2007).
24. Gordeuk V, Thuma P, Brittenham G et al. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N. Engl. J. Med. 327(21), 1473-1477 (1992).
25. Weiss G, Thuma PE, Mabeza G, Werner ER, Herold M, Gordeuk VR. Modulatory potential of iron chelation therapy on nitric oxide formation in cerebral malaria. J. Infect. Dis. 175(1), 226-230 (1997).
26. Watt G, Jongsakul K, Ruangvirayuth R. A pilot study of N-acetylcysteine as adjunctive therapy for severe malaria. Q. J. Med. 95(5), 285-290 (2002).
27. Hunt NH, Grau GE, Engwerda C et al. Murine cerebral malaria: the whole story. Trends Parasitol. 26(6), 272-274 (2010).
28. Stevenson MM, Gros P, Olivier M, Fortin A, Serghides L. Cerebral malaria: human versus mouse studies. Trends Parasitol. 26(6), 274-275 (2010).
29. Miyazaki Y, Bunting M, Stafforini DM et al. Integrin aDb2 is dynamically expressed by infamed macrophages and alters the natural history of lethal systemic infections. J. Immunol. 180(1), 590-600 (2008).
30. Casals-Pascual C, Idro R, Picot S, Roberts DJ, Newton CR. Can erythropoietin be used to prevent brain damage in cerebral malaria? Trends Parasitol. 25(1), 30-36 (2009).
31. Cabrales P, Zanini GM, Meays D, Frangos JA, Carvalho LJ. Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine. Am. J. Pathol. 176(3), 1306-1315 (2010).